Novel type of flow injection immunoassay for the determination of phenytoin in serum

Andrea Bereczki, V. Horváth

Research output: Article

14 Citations (Scopus)

Abstract

A novel flow injection immunoassay using fluorimetric detection successfully measured an antiepileptic drug, phenytoin, from a serum background. The assay was based on the competitive binding of fluorescein labelled and unlabelled phenytoin followed by the separation of bound and unbound antigens with gel filtration chromatography. The immunoreaction and subsequent detection of products was performed in a newly designed stopped flow injection system employing a simple two injector system for reagent injection, mixing and rigorous timing of the incubation. Two experimental set-ups were tested. The optimal parameters and configurations of the systems were established and the results were verified against an independent method. The calibration curves were linear showing good sensitivity and reproducibility in the concentration range required for clinical analyses suggesting that this technique could be a viable alternative for the measurement of the phenytoin in serum samples. Copyright (C) 1999 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)9-17
Number of pages9
JournalAnalytica Chimica Acta
Volume391
Issue number1
DOIs
Publication statusPublished - máj. 26 1999

Fingerprint

immunoassay
Phenytoin
Immunoassay
serum
Injections
antigen
Serum
chromatography
drug
Competitive Binding
gel
incubation
assay
Chromatography
calibration
Fluorescein
Anticonvulsants
Calibration
Gel Chromatography
Assays

ASJC Scopus subject areas

  • Biochemistry
  • Analytical Chemistry
  • Spectroscopy
  • Environmental Chemistry

Cite this

Novel type of flow injection immunoassay for the determination of phenytoin in serum. / Bereczki, Andrea; Horváth, V.

In: Analytica Chimica Acta, Vol. 391, No. 1, 26.05.1999, p. 9-17.

Research output: Article

@article{87ffcef8943d46039198c50baf3dec0a,
title = "Novel type of flow injection immunoassay for the determination of phenytoin in serum",
abstract = "A novel flow injection immunoassay using fluorimetric detection successfully measured an antiepileptic drug, phenytoin, from a serum background. The assay was based on the competitive binding of fluorescein labelled and unlabelled phenytoin followed by the separation of bound and unbound antigens with gel filtration chromatography. The immunoreaction and subsequent detection of products was performed in a newly designed stopped flow injection system employing a simple two injector system for reagent injection, mixing and rigorous timing of the incubation. Two experimental set-ups were tested. The optimal parameters and configurations of the systems were established and the results were verified against an independent method. The calibration curves were linear showing good sensitivity and reproducibility in the concentration range required for clinical analyses suggesting that this technique could be a viable alternative for the measurement of the phenytoin in serum samples. Copyright (C) 1999 Elsevier Science B.V.",
keywords = "Flow injection immunoassay, Fluorescence, Phenytoin",
author = "Andrea Bereczki and V. Horv{\'a}th",
year = "1999",
month = "5",
day = "26",
doi = "10.1016/S0003-2670(99)00205-6",
language = "English",
volume = "391",
pages = "9--17",
journal = "Analytica Chimica Acta",
issn = "0003-2670",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Novel type of flow injection immunoassay for the determination of phenytoin in serum

AU - Bereczki, Andrea

AU - Horváth, V.

PY - 1999/5/26

Y1 - 1999/5/26

N2 - A novel flow injection immunoassay using fluorimetric detection successfully measured an antiepileptic drug, phenytoin, from a serum background. The assay was based on the competitive binding of fluorescein labelled and unlabelled phenytoin followed by the separation of bound and unbound antigens with gel filtration chromatography. The immunoreaction and subsequent detection of products was performed in a newly designed stopped flow injection system employing a simple two injector system for reagent injection, mixing and rigorous timing of the incubation. Two experimental set-ups were tested. The optimal parameters and configurations of the systems were established and the results were verified against an independent method. The calibration curves were linear showing good sensitivity and reproducibility in the concentration range required for clinical analyses suggesting that this technique could be a viable alternative for the measurement of the phenytoin in serum samples. Copyright (C) 1999 Elsevier Science B.V.

AB - A novel flow injection immunoassay using fluorimetric detection successfully measured an antiepileptic drug, phenytoin, from a serum background. The assay was based on the competitive binding of fluorescein labelled and unlabelled phenytoin followed by the separation of bound and unbound antigens with gel filtration chromatography. The immunoreaction and subsequent detection of products was performed in a newly designed stopped flow injection system employing a simple two injector system for reagent injection, mixing and rigorous timing of the incubation. Two experimental set-ups were tested. The optimal parameters and configurations of the systems were established and the results were verified against an independent method. The calibration curves were linear showing good sensitivity and reproducibility in the concentration range required for clinical analyses suggesting that this technique could be a viable alternative for the measurement of the phenytoin in serum samples. Copyright (C) 1999 Elsevier Science B.V.

KW - Flow injection immunoassay

KW - Fluorescence

KW - Phenytoin

UR - http://www.scopus.com/inward/record.url?scp=0344689995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344689995&partnerID=8YFLogxK

U2 - 10.1016/S0003-2670(99)00205-6

DO - 10.1016/S0003-2670(99)00205-6

M3 - Article

AN - SCOPUS:0344689995

VL - 391

SP - 9

EP - 17

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

SN - 0003-2670

IS - 1

ER -